0001567619-22-020603.txt : 20221118 0001567619-22-020603.hdr.sgml : 20221118 20221118153347 ACCESSION NUMBER: 0001567619-22-020603 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20221118 DATE AS OF CHANGE: 20221118 EFFECTIVENESS DATE: 20221118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Epsilon Healthcare Innovation Fund II, LP CENTRAL INDEX KEY: 0001948657 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-465330 FILM NUMBER: 221401737 BUSINESS ADDRESS: STREET 1: 1227 25TH STREET NW STE 700 CITY: WASHINGTON STATE: DC ZIP: 20037 BUSINESS PHONE: 2026027213 MAIL ADDRESS: STREET 1: 1227 25TH STREET NW STE 700 CITY: WASHINGTON STATE: DC ZIP: 20037 D 1 primary_doc.xml X0708 D LIVE 0001948657 Epsilon Healthcare Innovation Fund II, LP 1227 25th Street NW SUITE 700 WASHINGTON DC DISTRICT OF COLUMBIA 20037 2026027213 DELAWARE None None Limited Partnership true 2022 Gregory H. Epstein 1227 25TH STREET NW SUITE 700 WASHINGTON DC DISTRICT OF COLUMBIA 20037 Executive Officer Director Manager of Epsilon Healthcare Innovation Fund II GP, LLC, "General Partner" of the Issuer Steven B. Epstein 1227 25TH STREET NW SUITE 700 WASHINGTON DC DISTRICT OF COLUMBIA 20037 Executive Officer Director Manager of the General Partner of the Issuer Stevens Andrew Brady 1227 25TH STREET NW SUITE 700 WASHINGTON DC DISTRICT OF COLUMBIA 20037 Executive Officer Officer of the General Partner of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C.7 false true true true true false 100000 50000000 0 50000000 false 0 0 0 1000000 true Estimated management fees payable during 1st year of the investment period of the Issuer based on aggregate commitments of $50,000,000. Add'l fees are payable for remainder of term of Issuer described in the confidential offering materials of the Issuer. false Epsilon Healthcare Innovation Fund II, LP /s/ Stevens Brady Stevens Brady Officer of the General Partner of the Issuer 2022-11-18